Drug and biotech stocks soar on Trump victory
NEW YORK (CNNMoney) -- Many health care investors are breathing a sigh of relief now that Donald Trump has defeated Hillary Clinton in the presidential race. Shares of pharmaceutical giants and big biotech firms surged Wednesday, largely due to hopes that a President Trump will not be as concerned about high drug prices as Clinton would have been.